[HTML][HTML] Sodium-glucose cotransporter 2 inhibitors attenuate vascular calcification by suppressing endoplasmic reticulum protein thioredoxin domain containing 5 …
S Wu, X Luo, Y Chen, Z Wang, X Liu, N Sun, J Zhao… - Redox Biology, 2024 - Elsevier
Aims Vascular calcification is strongly linked to the development of major adverse
cardiovascular events, but effective treatments are lacking. Sodium-glucose cotransporter 2 …
cardiovascular events, but effective treatments are lacking. Sodium-glucose cotransporter 2 …
Cardiovascular and kidney risks in persons with type 2 diabetes: Contemporary understanding with greater emphasis on excess adiposity
In high income countries, rates of atherosclerotic complications in type 2 diabetes have
declined markedly over time due to better management of traditional risk factors including …
declined markedly over time due to better management of traditional risk factors including …
[HTML][HTML] CVOT Summit Report 2023: new cardiovascular, kidney, and metabolic outcomes
O Schnell, K Barnard-Kelly, T Battelino… - Cardiovascular …, 2024 - Springer
Abstract The 9th Cardiovascular Outcome Trial (CVOT) Summit: Congress on
Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November 30 …
Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November 30 …
[HTML][HTML] Overweight and Obesity in Adults with Type 1 Diabetes: A Growing Challenge
The prevalence of obesity in adults with type 1 diabetes is increasing and reflects the rates
of the general adult population. The coexistence of overweight or obesity and type 1 …
of the general adult population. The coexistence of overweight or obesity and type 1 …
[HTML][HTML] The Ketogenic Effect of SGLT-2 Inhibitors—Beneficial or Harmful?
M Koutentakis, J Kuciński, D Świeczkowski… - Journal of …, 2023 - mdpi.com
Sodium–glucose cotransporter-2 (SGLT-2) inhibitors, also called gliflozins or flozins, are a
class of drugs that have been increasingly used in the management of type 2 diabetes …
class of drugs that have been increasingly used in the management of type 2 diabetes …
[HTML][HTML] Therapeutic strategies targeting mechanisms of macrophages in diabetic heart disease
C Zhang, Y Shi, C Liu, SM Sudesh, Z Hu, P Li… - Cardiovascular …, 2024 - Springer
Diabetic heart disease (DHD) is a serious complication in patients with diabetes. Despite
numerous studies on the pathogenic mechanisms and therapeutic targets of DHD, effective …
numerous studies on the pathogenic mechanisms and therapeutic targets of DHD, effective …
[HTML][HTML] Incidence of stroke, subsequent clinical outcomes and health care resource utilization in people with type 2 diabetes: a real-world database study in France:“ …
K Mohammedi, L Fauchier, N Quignot… - Cardiovascular …, 2024 - Springer
Background People with type 2 diabetes (T2D) are at elevated risk of cardiovascular
disease (CVD) including stroke, yet existing real-world evidence (RWE) on the clinical and …
disease (CVD) including stroke, yet existing real-world evidence (RWE) on the clinical and …
A pharmacovigilance study of chronic kidney disease in diabetes mellitus patients with statin treatment by using the US Food and Drug Administration adverse event …
J Zhang, Y Guo, C Wei, Y Yan, H Shan… - Frontiers in …, 2024 - frontiersin.org
Background Statins were regarded as a main medication for managing
hypercholesterolemia. Administration of statin therapy could reduce the incidence of …
hypercholesterolemia. Administration of statin therapy could reduce the incidence of …
A New Age for Secondary Prevention: Optimal Medical Therapy for Stable Ischemic Heart Disease Among Patients with Diabetes and/or Obesity
N Osude, NJ Pagidipati - Medical Clinics, 2024 - medical.theclinics.com
A New Age for Secondary Prevention: Optimal Medical Therapy for Stable Ischemic Heart
Disease Among Patients with Diabetes and/or Obesity - Medical Clinics Skip to Main Content …
Disease Among Patients with Diabetes and/or Obesity - Medical Clinics Skip to Main Content …
[HTML][HTML] Implantable cardioverter defibrillator and cardiac resynchronization treatment in people with type 2 diabetes: a comparison with age-and sex matched controls …
E Rautio, F Gadler, S Gudbjörnsdottir… - Cardiovascular …, 2024 - Springer
Background Increased risk of severe tachyarrhythmias is reported in patients with type 2
diabetes mellitus (T2DM). The aim of this study was to explore if treatment with cardiac …
diabetes mellitus (T2DM). The aim of this study was to explore if treatment with cardiac …